NO20000961L - Nye vevs-spesifikke calpainer, samt fremgangsmåte for fremstilling og anvendelse derav - Google Patents

Nye vevs-spesifikke calpainer, samt fremgangsmåte for fremstilling og anvendelse derav

Info

Publication number
NO20000961L
NO20000961L NO20000961A NO20000961A NO20000961L NO 20000961 L NO20000961 L NO 20000961L NO 20000961 A NO20000961 A NO 20000961A NO 20000961 A NO20000961 A NO 20000961A NO 20000961 L NO20000961 L NO 20000961L
Authority
NO
Norway
Prior art keywords
well
preparation
methods
new tissue
specific
Prior art date
Application number
NO20000961A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000961D0 (no
Inventor
Thomas Boehm
Neil T Dear
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20000961D0 publication Critical patent/NO20000961D0/no
Publication of NO20000961L publication Critical patent/NO20000961L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472Cysteine endopeptidases (3.4.22)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96466Cysteine endopeptidases (3.4.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Analytical Chemistry (AREA)
NO20000961A 1997-08-26 2000-02-25 Nye vevs-spesifikke calpainer, samt fremgangsmåte for fremstilling og anvendelse derav NO20000961L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19737105A DE19737105A1 (de) 1997-08-26 1997-08-26 Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung
PCT/EP1998/005275 WO1999010480A2 (de) 1997-08-26 1998-08-19 Neue gewebsspezifische calpaine, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
NO20000961D0 NO20000961D0 (no) 2000-02-25
NO20000961L true NO20000961L (no) 2000-04-14

Family

ID=7840195

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000961A NO20000961L (no) 1997-08-26 2000-02-25 Nye vevs-spesifikke calpainer, samt fremgangsmåte for fremstilling og anvendelse derav

Country Status (13)

Country Link
EP (1) EP1009811A2 (de)
JP (1) JP2001513992A (de)
KR (1) KR20010023282A (de)
CN (1) CN1277634A (de)
AU (1) AU9263598A (de)
BR (1) BR9811365A (de)
CA (1) CA2301815A1 (de)
DE (1) DE19737105A1 (de)
HU (1) HUP0004027A2 (de)
IL (1) IL134361A0 (de)
NO (1) NO20000961L (de)
WO (1) WO1999010480A2 (de)
ZA (1) ZA987660B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19928021A1 (de) * 1999-06-18 2000-12-21 Basf Ag Neue Calpaine und deren Verwendung
AU7476900A (en) * 1999-09-09 2001-04-10 Millennium Pharmaceuticals, Inc. 26176, a novel calpain protease and uses thereof
AU4422401A (en) * 2000-03-28 2001-10-08 Bayer Aktiengesellschaft Regulation of human neutral protease-related enzyme
AUPQ656500A0 (en) * 2000-03-28 2000-04-20 Autogen Pty Ltd A method of treatment and agents for same
WO2002081684A2 (en) * 2001-04-04 2002-10-17 Universite De Montreal Antisense calpain nucleotides and uses thereof
JP4593404B2 (ja) * 2005-08-29 2010-12-08 シスメックス株式会社 液体試料吸引監視方法及び装置、並びに液体試料分析装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4429385B2 (ja) * 1994-07-15 2010-03-10 セフアロン・インコーポレーテツド バキュロウイルスにより発現される活性カルパイン
EP0799892A3 (de) * 1996-04-05 1998-08-12 Takeda Chemical Industries, Ltd. Calpain, seine Herstellung und Verwendung

Also Published As

Publication number Publication date
ZA987660B (en) 2000-02-25
BR9811365A (pt) 2000-08-22
KR20010023282A (ko) 2001-03-26
CN1277634A (zh) 2000-12-20
WO1999010480A3 (de) 1999-05-27
DE19737105A1 (de) 1999-03-04
IL134361A0 (en) 2001-04-30
JP2001513992A (ja) 2001-09-11
EP1009811A2 (de) 2000-06-21
AU9263598A (en) 1999-03-16
CA2301815A1 (en) 1999-03-04
WO1999010480A2 (de) 1999-03-04
HUP0004027A2 (en) 2001-03-28
NO20000961D0 (no) 2000-02-25

Similar Documents

Publication Publication Date Title
NO973009L (no) Fremgangsmåte for å inhibere kathepsin-k
DK0692610T3 (da) Borehulsredskab, borehulsglideventil og fremgangsmåde til stimulering af en underjordisk formation
EA199700186A1 (ru) Новые дипептидные амидины, используемые в качестве ингибиторов тромбина
NO975336D0 (no) Elastomerisk kompound omfattende silisiumbehandlet sot, og fremgangsmåte for fremstilling av slik
AU3738597A (en) Molecular model for vla-4 inhibitors
NO941182L (no) Fremgangsmåte og fluid, samt porös pakking for behandling av en underjordisk formasjon
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
DK0890359T3 (da) Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf
FI20030162A7 (fi) Uusia yhdisteitä
FI972935A0 (fi) Kalpaiinin ja/tai katepsiini B:n substituoituja oksatsolidiiniestäjiä
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
TR199901057T2 (de)
AU3005997A (en) Inhibitors of picornavirus 3c proteases and methods for their use and preparation
FI962445A7 (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
FI942625L (fi) Peptidisiä fosfinyylioksimetyyliketoneja interleukiini-1beta-muuttuvan entsyymin inhibiittoreina
NO952967L (no) Tetningstilsats, fraktureringsfluid og fremgangsmåte for frakturering av en underjordisk formasjon
NO20000961L (no) Nye vevs-spesifikke calpainer, samt fremgangsmåte for fremstilling og anvendelse derav
DK0565502T4 (da) Bjergboremaskine og fremgangsmåde til at betjene den
NO990913D0 (no) Naftylforbindelser, intermediater, sammensetninger og metoder for anvendelse
EP0909172A4 (de) Verfahren und zusammensetzungen zur behandlung von harninkontinenz unter verwendung von enantiomer-angereichertem (r,s)-glycopyrrolat
NO973644D0 (no) Fremgangsmåte for stimulering av en underjordisk brönn
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer
NO991097L (no) Nye fremgangsmÕter
NO981578D0 (no) FremgangsmÕte for hemming av plasminogenaktivatorhemmer I
WO2000009653A3 (en) Method of inhibiting cathepsin k

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application